BIORA THERAPEUTICS INC (PROG)

US74319F1075 - Common Stock

0.8845  -0.03 (-3.47%)

After market: 0.9 +0.02 (+1.75%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.25M74.30M144.00M128.00M
Cost Of Goods
0.0093.40M100.50M92.10M
Gross Profit
1.25M-19.10M43.50M35.90M
Operating Expenses
119.08M176.10M183.60M150.10M
Research and Development
45.78M47.70M63.40M48.70M
Selling, General, and Administrative Expenses
73.30M128.30M120.20M101.40M
Operating Income
-117.84M-195.20M-140.10M-114.20M
Interest Income/Expense
-66.79M-10.00M-9.20M-11.40M
Other Income/Expense
6.89M-24.90M600.00K1.80M
Non Recurring Items
-900.00KN/AN/AN/A
Income Before Taxes
-178.64M-230.10M-148.70M-123.90M
Income Tax
-119.00K-37.50M-700.00K5.30M
Net Income
-247.41M-192.50M-148.00M-129.10M
EBITDA
-116.40M-190.14M-133.75M-108.13M
 
Per Share Data
EPS Diluted Total Ops
-2.57-7.00-3.27-2.86
Non GAAP EPS
-2.23N/AN/AN/A
 
Statistics
Gross Profit Margin
100.00%-25.71%30.21%28.05%
Profit Margin
-19840.58%-259.08%-102.78%-100.86%
Operating Profit Margin
-9449.64%-262.72%-97.29%-89.22%

All data in USD

Charts